TransMedics Group (TMDX)

Common Shares
Sell: $120.30|Buy: $122.70|Change: 0.86 (-0.71%)

Company profile

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Address





Sector 

Healthcare


Previous key dates

NameKey Date
Piper Sandler 37th Annual Healthcare Conference2025-12-02T09:30:00
TransMedics Group Inc Third Quarter Earnings Conference Call for 20252025-10-29T16:30:00
TransMedics Group Inc Third Quarter Earnings Result for 20252025-10-29T00:00:00
Baird 2025 Global Healthcare Conference2025-09-09T12:15:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-08T10:00:00
Canaccord Genuity 45th Annual Growth Conference2025-08-12T11:30:00
TransMedics Group Inc Second Quarter Earnings Conference Call for 20252025-07-30T16:30:00
TransMedics Group Inc Second Quarter Earnings Result for 20252025-07-30T00:00:00
Goldman sachs 46th annual global healthcare conference2025-06-09T08:00:00
William blair 45th annual growth stock conference2025-06-03T17:00:00
TransMedics Group Inc Annual General Meeting for 20252025-05-22T08:00:00
TransMedics Group Inc First Quarter Earnings Conference Call for 20252025-05-08T16:30:00
TransMedics Group Inc First Quarter Earnings Result for 20252025-05-08T00:00:00
Oppenheimer 35th Annual Healthcare MedTech & Services Conference2025-03-17T09:20:00
TD Cowen 45th Annual Health Care Conference2025-03-03T11:50:00
TransMedics Group Inc Fourth Quarter Earnings Conference Call for 20242025-02-27T16:30:00
TransMedics Group Inc Fourth Quarter Earnings Result for 20242025-02-27T00:00:00
TransMedics Group Inc Annual Report for 20242025-02-27T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T14:15:00
TransMedics Investor & Analyst Day Details2024-12-10T10:00:00
TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference2024-12-03T16:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.